Submission Number: 00002 

Received: 7/27/2011 4:01:45 PM
Commenter: Virginia Shareholder
Organization: 
State: California
Agency: Federal Trade Commission
Initiative: Proposed Consent Agreement In the Matter of Cardinal Health, Inc., File No. 0910136
Attachments: No Attachments
Submission Text
Why was Cardinal Health allowed to buy Biotech in the first place if a monopoly was going to be the outcome. It looks to me like there is going to be some back door dealmaking going on among all parties involved including the FTC. Once again the shareholders will probably lose out